Palforzia (peanut powder) capsules have been approved by the NHS for improving tolerance of children aged 4 to 17 year olds with peanut allergy (click here).
This follows two large clinical trials ARTEMIS and PALISADE which our network allergist Dr Vibha Sharma was involved in as a regional principle investigator. NICE guidelines are currently being developed, which will clarify referral and treatment pathways.
Technical appraisal guidance has recently been published by NICE. Please watch this space for further information prior to any referral to our service.